{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T16:16:30Z","timestamp":1788365790938,"version":"build-2803163510"},"reference-count":44,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,8,10]],"date-time":"2025-08-10T00:00:00Z","timestamp":1754784000000},"content-version":"am","delay-in-days":282,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"NCI","doi-asserted-by":"publisher","award":["P30 CA015704"],"award-info":[{"award-number":["P30 CA015704"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","gynecologiconcology-online.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gynecologic Oncology"],"published-print":{"date-parts":[[2024,11]]},"DOI":"10.1016\/j.ygyno.2024.07.690","type":"journal-article","created":{"date-parts":[[2024,8,10]],"date-time":"2024-08-10T09:26:50Z","timestamp":1723282010000},"page":"18-27","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Increased TP53 somatic evolution in peritoneal washes of individuals with BRCA1 germline mutations"],"prefix":"10.1016","volume":"190","author":[{"given":"Xin Ray","family":"Tee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emma","family":"Hazard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Latorre-Esteves","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brendan F.","family":"Kohrn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Talayeh S.","family":"Ghezelayagh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeanne Uy","family":"Fredrickson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"CoohleenAnn","family":"Coombes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc R.","family":"Radke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enna","family":"Manhardt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronit","family":"Katz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T. Rinda","family":"Soong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth M.","family":"Swisher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara M.","family":"Norquist","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosa Ana","family":"Risques","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"11","key":"10.1016\/j.ygyno.2024.07.690_bb0005","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1038\/nrc4019","article-title":"Rethinking ovarian cancer II: reducing mortality from high-grade serous ovarian cancer","volume":"15","author":"Bowtell","year":"2015","journal-title":"Nat. Rev. Cancer"},{"issue":"23","key":"10.1016\/j.ygyno.2024.07.690_bb0010","doi-asserted-by":"crossref","first-page":"2402","DOI":"10.1001\/jama.2017.7112","article-title":"Risks of breast, ovarian, and contralateral breast Cancer for BRCA1 and BRCA2 mutation carriers","volume":"317","author":"Kuchenbaecker","year":"2017","journal-title":"JAMA"},{"issue":"4","key":"10.1016\/j.ygyno.2024.07.690_bb0015","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1158\/1055-9965.EPI-14-1128","article-title":"Population distribution of lifetime risk of ovarian cancer in the United States","volume":"24","author":"Pearce","year":"2015","journal-title":"Cancer Epidemiol. Biomarkers Prev."},{"issue":"4","key":"10.1016\/j.ygyno.2024.07.690_bb0020","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1001\/jamaoncol.2015.5495","article-title":"Inherited mutations in women with ovarian carcinoma","volume":"2","author":"Norquist","year":"2016","journal-title":"JAMA Oncol."},{"issue":"15","key":"10.1016\/j.ygyno.2024.07.690_bb0025","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1200\/JCO.2013.53.2820","article-title":"Impact of oophorectomy on cancer incidence and mortality in women with a BRCA1 or BRCA2 mutation","volume":"32","author":"Finch","year":"2014","journal-title":"J. Clin. Oncol."},{"issue":"2","key":"10.1016\/j.ygyno.2024.07.690_bb0030","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1016\/j.ygyno.2020.02.006","article-title":"Pathologic findings and clinical outcomes in women undergoing risk-reducing surgery to prevent ovarian and fallopian tube carcinoma: a large prospective single institution experience","volume":"157","author":"Rush","year":"2020","journal-title":"Gynecol. Oncol."},{"issue":"1","key":"10.1016\/j.ygyno.2024.07.690_bb0035","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.ajpath.2020.09.006","article-title":"The origin of ovarian cancer species and precancerous landscape","volume":"191","author":"Shih","year":"2021","journal-title":"Am. J. Pathol."},{"issue":"1","key":"10.1016\/j.ygyno.2024.07.690_bb0040","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1038\/s41467-017-00962-1","article-title":"High grade serous ovarian carcinomas originate in the fallopian tube","volume":"8","author":"Labidi-Galy","year":"2017","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.ygyno.2024.07.690_bb0045","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1002\/path.5219","article-title":"Genomic landscape and evolutionary trajectories of ovarian cancer precursor lesions","volume":"248","author":"Wu","year":"2019","journal-title":"J. Pathol."},{"issue":"7793","key":"10.1016\/j.ygyno.2024.07.690_bb0050","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1038\/s41586-019-1907-7","article-title":"The evolutionary history of 2,658 cancers","volume":"578","author":"Gerstung","year":"2020","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.ygyno.2024.07.690_bb0055","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/j.ygyno.2018.11.033","article-title":"The fallopian tube, \u201cprecursor escape\u201d and narrowing the knowledge gap to the origins of high-grade serous carcinoma","volume":"152","author":"Soong","year":"2019","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2024.07.690_bb0060","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.ygyno.2024.05.010","article-title":"Does serous tubal intraepithelial carcinoma (STIC) metastasize? The clonal relationship between STIC and subsequent high-grade serous carcinoma in BRCA1\/2 mutation carriers several years after risk-reducing salpingo-oophorectomy","volume":"187","author":"Berg","year":"2024","journal-title":"Gynecol. Oncol."},{"issue":"5","key":"10.1016\/j.ygyno.2024.07.690_bb0065","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1038\/nrg.2017.117","article-title":"Enhancing the accuracy of next-generation sequencing for detecting rare and subclonal mutations","volume":"19","author":"Salk","year":"2018","journal-title":"Nat. Rev. Genet."},{"issue":"36","key":"10.1016\/j.ygyno.2024.07.690_bb0070","doi-asserted-by":"crossref","first-page":"14508","DOI":"10.1073\/pnas.1208715109","article-title":"Detection of ultra-rare mutations by next-generation sequencing","volume":"109","author":"Schmitt","year":"2012","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"21","key":"10.1016\/j.ygyno.2024.07.690_bb0075","doi-asserted-by":"crossref","first-page":"6005","DOI":"10.1073\/pnas.1601311113","article-title":"Ultra-deep sequencing detects ovarian cancer cells in peritoneal fluid and reveals somatic TP53 mutations in noncancerous tissues","volume":"113","author":"Krimmel","year":"2016","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"1","key":"10.1016\/j.ygyno.2024.07.690_bb0080","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.celrep.2019.05.109","article-title":"Ultra-sensitive TP53 sequencing for cancer detection reveals progressive clonal selection in normal tissue over a century of human lifespan","volume":"28","author":"Salk","year":"2019","journal-title":"Cell Rep."},{"issue":"10","key":"10.1016\/j.ygyno.2024.07.690_bb0085","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1158\/2767-9764.CRC-22-0314","article-title":"Uterine lavage identifies cancer mutations and increased TP53 somatic mutation burden in individuals with ovarian cancer","volume":"2","author":"Ghezelayagh","year":"2022","journal-title":"Cancer Res. Commun."},{"issue":"2","key":"10.1016\/j.ygyno.2024.07.690_bb0090","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.ygyno.2019.11.124","article-title":"Characterization of TP53 mutations in Pap test DNA of women with and without serous ovarian carcinoma","volume":"156","author":"Krimmel-Morrison","year":"2020","journal-title":"Gynecol. Oncol."},{"issue":"31","key":"10.1016\/j.ygyno.2024.07.690_bb0095","doi-asserted-by":"crossref","first-page":"2421","DOI":"10.1038\/s41388-024-03089-y","article-title":"TP53 somatic evolution in cervical liquid-based cytology and blood from individuals with and without ovarian cancer and BRCA1 or BRCA2 germline mutations","volume":"43","author":"Ghezelayagh","year":"2024","journal-title":"Oncogene"},{"issue":"4","key":"10.1016\/j.ygyno.2024.07.690_bb0100","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1038\/s41568-021-00335-3","article-title":"Clonal expansion in non-cancer tissues","volume":"21","author":"Kakiuchi","year":"2021","journal-title":"Nat. Rev. Cancer"},{"issue":"1","key":"10.1016\/j.ygyno.2024.07.690_bb0105","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/s13073-019-0648-4","article-title":"Somatic mutation and clonal expansions in human tissues","volume":"11","author":"Martincorena","year":"2019","journal-title":"Genome Med."},{"issue":"1","key":"10.1016\/j.ygyno.2024.07.690_bb0110","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1007108","article-title":"Aging and the rise of somatic cancer-associated mutations in normal tissues","volume":"14","author":"Risques","year":"2018","journal-title":"PLoS Genet."},{"issue":"7","key":"10.1016\/j.ygyno.2024.07.690_bb0115","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1158\/1940-6207.CAPR-22-0469","article-title":"Clonal evolution in healthy and premalignant tissues: implications for early Cancer interception strategies","volume":"16","author":"Rane","year":"2023","journal-title":"Cancer Prev. Res. (Phila.)"},{"issue":"1","key":"10.1016\/j.ygyno.2024.07.690_bb0120","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1152\/physrev.00004.2022","article-title":"Clonal hematopoiesis, somatic mosaicism, and age-associated disease","volume":"103","author":"Evans","year":"2023","journal-title":"Physiol. Rev."},{"issue":"6444","key":"10.1016\/j.ygyno.2024.07.690_bb0125","doi-asserted-by":"crossref","DOI":"10.1126\/science.aaw0726","article-title":"RNA sequence analysis reveals macroscopic somatic clonal expansion across normal tissues","volume":"364","author":"Yizhak","year":"2019","journal-title":"Science"},{"issue":"44","key":"10.1016\/j.ygyno.2024.07.690_bb0130","doi-asserted-by":"crossref","first-page":"18032","DOI":"10.1073\/pnas.1115052108","article-title":"Mutations in 12 genes for inherited ovarian, fallopian tube, and peritoneal carcinoma identified by massively parallel sequencing","volume":"108","author":"Walsh","year":"2011","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"11","key":"10.1016\/j.ygyno.2024.07.690_bb0135","doi-asserted-by":"crossref","first-page":"2586","DOI":"10.1038\/nprot.2014.170","article-title":"Detecting ultralow-frequency mutations by duplex sequencing","volume":"9","author":"Kennedy","year":"2014","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.ygyno.2024.07.690_bb0140","series-title":"R: A Language and Environment for Statistical Computing [Internet]","author":"R Core Team","year":"2022"},{"issue":"6664","key":"10.1016\/j.ygyno.2024.07.690_bb0145","doi-asserted-by":"crossref","DOI":"10.1126\/science.adg7492","article-title":"Accurate proteome-wide missense variant effect prediction with AlphaMissense","volume":"381","author":"Cheng","year":"2023","journal-title":"Science"},{"issue":"6","key":"10.1016\/j.ygyno.2024.07.690_bb0150","doi-asserted-by":"crossref","first-page":"1702","DOI":"10.1016\/j.ajog.2006.03.006","article-title":"Predictors of occult neoplasia in women undergoing risk-reducing salpingo-oophorectomy","volume":"194","author":"Lamb","year":"2006","journal-title":"Am. J. Obstet. Gynecol."},{"issue":"12","key":"10.1016\/j.ygyno.2024.07.690_bb0155","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1038\/ng.3441","article-title":"Clock-like mutational processes in human somatic cells","volume":"47","author":"Alexandrov","year":"2015","journal-title":"Nat. Genet."},{"issue":"4","key":"10.1016\/j.ygyno.2024.07.690_bb0160","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1158\/2159-8290.CD-23-1508","article-title":"Somatic mutations in normal tissues: calm before the storm","volume":"14","author":"Rahal","year":"2024","journal-title":"Cancer Discov."},{"issue":"3","key":"10.1016\/j.ygyno.2024.07.690_bb0165","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.stem.2017.07.010","article-title":"Therapy-related clonal hematopoiesis in patients with non-hematologic cancers is common and associated with adverse clinical outcomes","volume":"21","author":"Coombs","year":"2017","journal-title":"Cell Stem Cell"},{"issue":"11","key":"10.1016\/j.ygyno.2024.07.690_bb0170","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1038\/s41588-020-00710-0","article-title":"Cancer therapy shapes the fitness landscape of clonal hematopoiesis","volume":"52","author":"Bolton","year":"2020","journal-title":"Nat. Genet."},{"issue":"2","key":"10.1016\/j.ygyno.2024.07.690_bb0175","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1038\/s41416-019-0492-8","article-title":"Mendelian randomisation study of height and body mass index as modifiers of ovarian cancer risk in 22,588 BRCA1 and BRCA2 mutation carriers","volume":"121","author":"Qian","year":"2019","journal-title":"Br. J. Cancer"},{"issue":"11","key":"10.1016\/j.ygyno.2024.07.690_bb0180","doi-asserted-by":"crossref","first-page":"2038","DOI":"10.1158\/1055-9965.EPI-21-0296","article-title":"Weight gain and the risk of ovarian cancer in BRCA1 and BRCA2 mutation carriers","volume":"30","author":"Kim","year":"2021","journal-title":"Cancer Epidemiol. Biomarkers Prev."},{"issue":"7","key":"10.1016\/j.ygyno.2024.07.690_bb0185","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.1016\/j.celrep.2018.07.037","article-title":"Clonal expansion and diversification of cancer-associated mutations in endometriosis and normal endometrium","volume":"24","author":"Suda","year":"2018","journal-title":"Cell Rep."},{"issue":"7805","key":"10.1016\/j.ygyno.2024.07.690_bb0190","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1038\/s41586-020-2214-z","article-title":"The mutational landscape of normal human endometrial epithelium","volume":"580","author":"Moore","year":"2020","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.ygyno.2024.07.690_bb0195","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1038\/s41467-022-28568-2","article-title":"Spatiotemporal dynamics of clonal selection and diversification in normal endometrial epithelium","volume":"13","author":"Yamaguchi","year":"2022","journal-title":"Nat. Commun."},{"issue":"6465","key":"10.1016\/j.ygyno.2024.07.690_bb0200","doi-asserted-by":"crossref","DOI":"10.1126\/science.aan4673","article-title":"Clonal hematopoiesis in human aging and disease","volume":"366","author":"Jaiswal","year":"2019","journal-title":"Science"},{"key":"10.1016\/j.ygyno.2024.07.690_bb0205","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.gde.2020.12.004","article-title":"Insights into clonal hematopoiesis and its relation to cancer risk","volume":"66","author":"Mitchell","year":"2021","journal-title":"Curr. Opin. Genet. Dev."},{"issue":"11","key":"10.1016\/j.ygyno.2024.07.690_bb0210","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1158\/1940-6207.CAPR-18-0009","article-title":"Fallopian tube lesions in women at high risk for ovarian cancer: a multicenter study","volume":"11","author":"Visvanathan","year":"2018","journal-title":"Cancer Prev. Res. (Phila.)"},{"issue":"22","key":"10.1016\/j.ygyno.2024.07.690_bb0215","doi-asserted-by":"crossref","first-page":"5261","DOI":"10.1002\/cncr.25439","article-title":"The molecular pathogenesis of hereditary ovarian carcinoma: alterations in the tubal epithelium of women with BRCA1m and BRCA2 mutations","volume":"116","author":"Norquist","year":"2010","journal-title":"Cancer"},{"issue":"2","key":"10.1016\/j.ygyno.2024.07.690_bb0220","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.ygyno.2008.01.012","article-title":"A candidate precursor to pelvic serous cancer (p53 signature) and its prevalence in ovaries and fallopian tubes from women with BRCA mutations","volume":"109","author":"Folkins","year":"2008","journal-title":"Gynecol. Oncol."}],"container-title":["Gynecologic Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825824010540?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825824010540?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T14:58:13Z","timestamp":1777474693000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090825824010540"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11]]},"references-count":44,"alternative-id":["S0090825824010540"],"URL":"https:\/\/doi.org\/10.1016\/j.ygyno.2024.07.690","relation":{},"ISSN":["0090-8258"],"issn-type":[{"value":"0090-8258","type":"print"}],"subject":[],"published":{"date-parts":[[2024,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Increased TP53 somatic evolution in peritoneal washes of individuals with BRCA1 germline mutations","name":"articletitle","label":"Article Title"},{"value":"Gynecologic Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ygyno.2024.07.690","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}